Clinical Trial Update: Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) [Phase 2, Phase 3]

View source ↗

Summary

The FASTER trial, a Phase 2/3 study conducted by the University of Calgary, evaluated rapid assessment to prevent early recurrence after transient ischemic atta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: University of Calgary | Conditions: Transient Ischemic Attack, Stroke | Phase 2, Phase 3 | Status: COMPLETED